The Aporia
Bickis, I. (2026, October 16). Ottawa confirms funding for rare disease research as other questions remain. Toronto Star. https://www.thestar.com/news/canada/manitoba/feds-confirm-funding-for-rare-disease-research-as-other-questions-unanswered/article_6407d33c-0881-54e1-aaae-dd0972680beb.html
Bickis, Ian. “Ottawa confirms funding for rare disease research as other questions remain.” Toronto Star, 16 Oct. 2026, https://www.thestar.com/news/canada/manitoba/feds-confirm-funding-for-rare-disease-research-as-other-questions-unanswered/article_6407d33c-0881-54e1-aaae-dd0972680beb.html.
Bickis, Ian. “Ottawa confirms funding for rare disease research as other questions remain.” Toronto Star, October 16, 2026. https://www.thestar.com/news/canada/manitoba/feds-confirm-funding-for-rare-disease-research-as-other-questions-unanswered/article_6407d33c-0881-54e1-aaae-dd0972680beb.html.
Dated from the outlet's own feed. Check the original for its byline.
As of October 16, 2026, Federal Health Minister Marjorie Michel announced at a meeting in Winnipeg with provincial and territorial counterparts that the $500 million annual funding for the National Strategy for Drugs for Rare Diseases will continue indefinitely. This decision came after concerns about the funding expiring next year. However, broader issues regarding health-care funding remain unresolved.